Skip to main content
. 2017 Jan 6;8(7):12145–12157. doi: 10.18632/oncotarget.14553

Figure 3. P3 GBM cells uniformly express high levels of CD47.

Figure 3

Cell suspensions were incubated with FITC-labeled anti-CD47 antibody used for treatment in rats or IgG as a control. A. Fluorescent image of P3 tumor cells incubated with FITC-labeled anti-CD47 antibody (green). DAPI (blue) was used for nuclear counterstaining. B. Analysis of CD47 expression by flow cytometry. Forward and side scatter plots of fixed cells, and percentage of cells FITC labeled (> 98%) in the gated population.